Diabetes and breast cancer risk: A meta-analysis

British Journal of Cancer

Volumn 107, Issue 9, 2012, Pages 1608-1617

  Boyle, P ^a   Boniol, M ^a,a   Koechlin, A ^a   Robertson, C ^a,b   Valentini, F ^a   Coppens, K ^a   Fairley, L L ^a   Zheng, T ^c   Zhang, Y ^c   Pasterk, M ^a   Smans, M ^a   Curado, M P ^a   Mullie, P ^a   Gandini, S ^a,d   Bota, M ^a   Bolli, G B ^e   Rosenstock, J ^f   Autier, P ^a  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c YALE UNIVERSITY   (United States)

^d EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^e UNIVERSITY OF PERUGIA   (Italy)

^f DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

Author keywords

body mass index; breast cancer; diabetes; meta analysis

Indexed keywords

ARTICLE; BODY MASS; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CONFIDENCE INTERVAL; DATA EXTRACTION; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MEDLINE; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREMENOPAUSE; PRIORITY JOURNAL; PUBLICATION; RISK FACTOR; SCISEARCH;

BODY MASS INDEX; BREAST NEOPLASMS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 84867899884     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.414     Document Type: Article

References (76)

1. Adami HO, McLaughlin J, Ekbom A, Berne C, Silvermand D, Hacker D, Persson I (1991) Cancer risk in patients with diabetes mellitus. Cancer Causes Control 2: 307-314
2. Adami HO, Rimsten A (1978) Prevalence of hypertension and diabetes in breast cancer: a case-control study in 179 patients and age-matched, non-hospitalized controls. Clin Oncol 4: 243-249
3. Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, Heanue M (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341: c3620
4. Barker BE, Fanger H, Farnes P (1964) Human mammary slices in organ culture. I. Methods of culture and preliminary observations on the effects of insulin. Exp Cell Res 35: 437-448
5. Baron JA, Weiderpass E, Newcomb PA, Stampfer M, Titus-Ernstoff L, Egan KM, Greenberg ER (2001) Metabolic disorders and breast cancer risk (United States). Cancer Causes Control 12: 875-880
6. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101
7. Beji NK, Reis N (2007) Risk factors for breast cancer in Turkish women: a hospital-based case-control study. Eur J Cancer Care 16: 178-184
8. Boyle P, Howell A (2010) The globalisation of breast cancer. Breast Cancer Res 12(Suppl 4): S7
9. Boyle P, Levin B (eds) (2008) World Cancer Report 2008. IARC: Lyon, France
10. Boyle P (2006) The Globalisation of cancer. Lancet 368: 629-630
11. Brown KA, Simpson ER (2010) Obesity and breast cancer: progress to understanding the relationship. Cancer Res 70: 4-7
12. Cannata D, Fierz Y, Vijayakumar A, Leroith D (2010) Type 2 diabetes and cancer: What is the connection? Mt Sinai J Med 77: 197-213
13. Conover CA, Lee PD, Kanaley JA, Clarkson JT, Jensen MD (1992) Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese humans. J Clin Endocrinol Metab 74: 1355-1360
14. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159: 1160-1167
15. De Waard F, Baanders-van Halewijn EA (1974) A prospective study in general practice on breast-cancer risk in postmenopausal women. Int J Cancer 14: 153-160
16. Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315: 1533-1537
17. Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26: 781-785
18. Freund E (1885) Diagnosis des Carcinomas. Wien Med B1: 268-268
19. Garmendia ML, Pereira A, Alvarado ME, Atalah E (2007) Relation between insulin resistance and breast cancer among Chilean women. Ann Epidemiol 17: 403-409
20. Glicksman AS, Rawson RW (1956) Diabetes and altered carbohydrate metabolism in patients with cancer. Cancer 9: 1127-1134
21. Goodman MT, Cologne JB, Moriwaki H, Vaeth M, Mabuchi K (1997) Risk factors for primary breast cancer in Japan: 8-year follow-up of atomic bomb survivors. Prev Med 26: 144-153
22. Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalisation for Type 2 diabetes. Oncologist 15: 548-555
23. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a metaanalysis. Stat Med 21: 1539-1558
24. Hjalgrim H, Frisch M, Ekbom A, Kyvik KO, Melbye M, Green A (1997) Cancer and diabetes-a follow-up study of two population-based cohorts of diabetic patients. J Intern Med 241: 471-475
25. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale populationbased cohort study in Japan. Arch Intern Med 166: 1871-1877
26. International Agency for Research on Cancer (2002) IARC Handbooks of Cancer Prevention, Vol. 5, Weight Control and Physical Activity. IARC: Lyon, France
27. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293: 194-202
28. Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumour characteristics among United States women. Breast Cancer Res 9: R28
29. Johnson JA, Bowker SL (2011) Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials. Diabetologia 54: 25-31
30. Jordan S, Lim L, Vilainerun D, Banks E, Sripaiboonkij N, Seubsman SA, Sleigh A, Bain C (2009) Breast cancer in the Thai Cohort Study: an exploratory case-control analysis. Breast 18: 299-303
31. Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7: 605-625
32. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, Washio M, Tamakoshi A (2006) Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 7: 253-259
33. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P (1994) A case-control study of diabetes mellitus and cancer risk. Br J Cancer 70: 950-953
34. Lambe M, Wigertz A, Gamo H, Walldius G, Jungner I, Hammar N (2011) Impaired glucose metabolism and diabetes and the risk of breast, endometrial and ovarian cancer. Cancer Causes Control 22: 1163-1171
35. Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121: 856-862
36. Lawlor DA, Davey Smith G, Ebrahim S (2004) Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 15: 267-275
37. Li C, Balluz LS, Ford ES, Okoro CA, Tsai J, Zhao G (2011) Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioural Risk Factors Surveillance System. Diabetes Care 34: 1365-1368
38. Liao S, Li J, Wei W, Wang L, Zhang Y, Li J, Wang C, Sun S (2011) Association between diabetes mellitus and breast cancer risk: a metaanalysis of the literature. Asian Pac J Cancer Prev 12: 1061-1065
39. Lippman ME, Bolan G (1975) Oestrogen responsive human breast cancer cells in long term tissue culture. Nature 256: 592-594
40. Lipscombe LL, Goodwin PJ, Zinman B, McLaughlin JR, Hux JE (2006) Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res Treat 98: 349-356
41. Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20: 641-654
42. Michels KB, Solomon CG, Hu FB, Rosner BA, Hankinson SE, Colditz GA, Manson JE (2003) Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study. Diabetes Care 26: 1752-1758
43. Mink PJ, Shahar E, Rosamond WD, Alberg AJ, Folsom AR (2002) Serum insulin and glucose levels and breast cancer incidence: the atherosclerosis risk in communities study. Am J Epidemiol 156: 349-352
44. Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22: 1000-1009
45. Muck BR, Trotnow S, Hommel G (1975) Cancer of the breast, diabetes and pathological glucose tolerance. Arch Gynäk 220: 73-81
46. Novosyadlyy R, Lann DE, Vijayakumar A, Rowzee A, Lazzarino DA, Fierz Y, Carboni JM, Gottardis MM, Pennisi PA, Molinolo AA, Kurshan N, Mejia W, Santopietro S, Yakar S, Wood TL, LeRoith D (2010) Insulinmediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes. Cancer Res 70: 741-751
47. O'Mara BA, Byers T, Schoenfeld E (1985) Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 38: 435-441
48. Plymate SR, Hoop RC, Jones RE, Matej LA (1990) Regulation of sex hormone-binding globulin production by growth factors. Metabolism 39: 967-970
49. Ragozzino M, Melton III LJ, Chu CP, Palumbo PJ (1982) Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 35: 13-19
50. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2006) Fasting blood glucose and cancer risk in a cohort of more than 140, 000 adults in Austria. Diabetologia 49: 945-952
51. Resta F, Triggiani V, Sabbà C, Licchelli B, Ghiyasaldin S, Liso A, Schittulli F, Quaranta M, Paradiso A, Tafaro E, Guastamacchia E (2004) The impact of body mass index and type 2 diabetes on breast cancer: current therapeutic measures of prevention. Curr Drug Targets Immune Endocr Metab Disord 4: 327-333
52. Rollison DA, Giulano AR, Sellers TA, Laronga C, Sweeney C, Risendal B, Baumgartner KB, Byers T, Slattery ML (2008) Population-based case-control study of diabetes and breast cancer risk in Hispanic and non-hispanic women living in US South-western States. Am J Epidemiol 167: 447-456
53. Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, Negri E, La Vecchia C (2011) Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol 22: 2687-2692
54. Rosner W (1990) The functions of corticosteroid-binding globulin and sex-hormone-binding globulin: recent advances. Endocr Rev 11: 80-91
55. Sanderson M, Peltz G, Perez A, Johnson M, Vernon SW, Fernandez ME, Fadden MK (2010) Diabetes, physical activity and breast cancer among Hispanic women. Cancer Epidemiol 34: 556-561
56. Sellers TA, Sprafka JM, Gapstur SM, Rich SS, Potter JD, Ross JA, McGovern PG, Nelson CL, Folsom AR (1994) Does body fat distribution promote familial aggregation of adult onset diabetes mellitus and postmenopausal breast cancer? Epidemiology 5: 102-108
57. Shin HR, Joubert C, Boniol M, Hery C, Ahn SH, Won YJ, Nishino Y, Sobue T, Chen CJ, You SL, Mirasol-Lumague MR, Law SC, Mang O, Xiang YB, Chia KS, Rattanamongkolgul S, Chen JG, Curado MP, Autier P (2010) Recent trends and patterns in breast cancer incidence among Eastern and South-eastern Asian women. Cancer Causes Control 21: 1777-1785
58. Sicree R, Shaw J, Zimmet P (2006) Diabetes and impaired glucose tolerance. In Diabetes Atlas. 3rd ednGan D (ed)pp 15-109. International Diabetes Federation: Brussels, Belgium
59. Sinagra D, Amato C, Scarpitta AM, Brigandi M, Amato M, Saura G, Latteri MA, Caimi G (2002) Metabolic syndrome and breast cancer risk. Eur Rev Med Pharmacol Sci 6: 55-59
60. Singh A, Hamilton-Fairley D, Koistinen R, Seppala M, James VH, Franks S, Reed MJ (1990) Effect of insulin-like growth factor-type I (IGF-I) and insulin on the secretion of sex-hormone binding globulin and IGF-I binding protein (IBP-I) by human hepatoma cells. J Endocrinol 124: R1-R3
61. Steenland K, Nowlin S, Palu S (1995) Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 4: 807-811
62. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012
63. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Gale EA, Patterson CC, Keen H (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92: 2070-2075
64. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75: 1699-1703
65. Tseng CH, Chong CK, Tai TY (2009) Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006. Diabetologia 52: 240-246
66. Van der Burg BB, Rutterman GR, Blankenstein MA, de Laat SW, van Zoelen EJJ (1988) Mitogenic stimulation of human breast cancer cells in a growth-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 134: 101-108
67. van Houwelingen HC, Arends LR, Stijnen T (2002) Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21: 589-624
68. Verlato G, Zoppini G, Bonora E, Muggeo M (2003) Mortality from sitespecific malignancies in type 2 diabetic patients from Verona. Diabetes Care 26: 1047-1051
69. Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36: 1-48
70. Warburg O (1930) The Metabolism of Tumors. Constable Press: London, United Kingdom
71. Weiderpass E, Gridley G, Persson I, Nyren O, Ekbom A, Adami HO (1997) Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 71: 360-363
72. Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD, Malone KE, Schoenberg JB (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28: 816-823
73. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S Borch-Johnsen K, Olsen JH (1997) Cancer incidence in a population based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89: 1360-1365
74. Wolf I, Sadetzki S, Catane R, Karasik A, Kaufman B (2005) Diabetes mellitus and breast cancer. Lancet Oncol 6: 103-111
75. Wu AH, Yu MC, Tseng C-C, Stanczyk FZ, Pike MC (2007) Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 28: 1561-1566
76. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W (2003) Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 95: 1797-1800